Antifungal chemotherapy in patients with acquired immunodeficiency syndrome. British Society for Antimicrobial Chemotherapy Working Party.
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications*; D000935:Antifungal Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001228:Aspergillosis / Q000188:drug therapy / Q000209:etiology / Q000517:prevention & control; D002180:Candidiasis, Oral / Q000188:drug therapy* / Q000209:etiology / Q000517:prevention & control; D002985:Clinical Protocols / Q000592:standards; D003047:Coccidioidomycosis / Q000188:drug therapy / Q000209:etiology / Q000517:prevention & control; D003453:Cryptococcosis / Q000188:drug therapy* / Q000209:etiology / Q000517:prevention & control; D004359:Drug Therapy, Combination; D006660:Histoplasmosis / Q000175:diagnosis* / Q000209:etiology / Q000517:prevention & control; D006801:Humans; D008172:Lung Diseases, Fungal / Q000188:drug therapy / Q000209:etiology / Q000517:prevention & control
D000935:Antifungal Agents